TIBER CREEK GROUP

Lobbying for ASTELLAS PHARMA US, INC. · Pharmacuetical company.

Filing 1st Quarter - Report

1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · Senate · $60,000.00 income · posted Apr 20, 2025

Lobbying activity 2

Health Issues

Issues related to the implementation of drug pricing and reimbursement for prescription drugs in the Inflation Reduction Act of 2022 (PL 117-169); Issues related to women's health; Issues related to oncology; Issues related to ophthalmology.

Medicare/Medicaid

Issues related to the implementation of drug pricing and reimbursement for prescription drugs in the Inflation Reduction Act of 2022 (PL 117-169).

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.